Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN955086 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-tyrosine Aminotransferase (TAT) (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Affinity Purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Middle Region
- Vial size
- 0.4 mL
Submitted references Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II.
Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells.
Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro.
TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.
Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations.
Pasternack SM, Betz RC, Brandrup F, Gade EF, Clemmensen O, Lund AM, Christensen E, Bygum A
The British journal of dermatology 2009 Mar;160(3):704-6
The British journal of dermatology 2009 Mar;160(3):704-6
Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells.
Liu S, Mao Q, Zhang W, Zheng X, Bian Y, Wang D, Li H, Chai L, Zhao J, Xia H
Bioscience reports 2009 Apr;29(2):103-9
Bioscience reports 2009 Apr;29(2):103-9
Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro.
Baharvand H, Hashemi SM, Kazemi Ashtiani S, Farrokhi A
The International journal of developmental biology 2006;50(7):645-52
The International journal of developmental biology 2006;50(7):645-52
TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.
Maydan G, Andresen BS, Madsen PP, Zeigler M, Raas-Rothschild A, Zlotogorski A, Gutman A, Korman SH
Journal of inherited metabolic disease 2006 Oct;29(5):620-6
Journal of inherited metabolic disease 2006 Oct;29(5):620-6
Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations.
Charfeddine C, Monastiri K, Mokni M, Laadjimi A, Kaabachi N, Perin O, Nilges M, Kassar S, Keirallah M, Guediche MN, Kamoun MR, Tebib N, Ben Dridi MF, Boubaker S, Ben Osman A, Abdelhak S
Molecular genetics and metabolism 2006 Jun;88(2):184-91
Molecular genetics and metabolism 2006 Jun;88(2):184-91
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS